☰

Jennifer Gilmore

Affiliations: 
2005 Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Google:
"Jennifer Gilmore"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
David J. Riese grad student 2005 Purdue

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nickerson NK, Mohammad KS, Gilmore JL, et al. (2012) Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. Plos One. 7: e30255
Foley J, Nickerson NK, Nam S, et al. (2010) EGFR signaling in breast cancer: bad to the bone. Seminars in Cell & Developmental Biology. 21: 951-60
Gilmore JL, Gonterman RM, Menon K, et al. (2009) Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. Molecular Cancer Research : McR. 7: 1714-28
Wilson KJ, Gilmore JL, Foley J, et al. (2009) Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacology & Therapeutics. 122: 1-8
Gilmore JL, Scott JA, Bouizar Z, et al. (2008) Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Research and Treatment. 110: 493-505
Gilmore JL, Gallo RM, Riese DJ. (2006) The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events. The Biochemical Journal. 396: 79-88
VanBrocklin HF, Lim JK, Coffing SL, et al. (2005) Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes. Journal of Medicinal Chemistry. 48: 7445-56
Gilmore JL, Riese DJ. (2004) secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation. Oncology Research. 14: 589-602
See more...